Literature DB >> 16741575

Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction.

Cinzia Perrino1, Sathyamangla V Naga Prasad, Lan Mao, Takahisa Noma, Zhen Yan, Hyung-Suk Kim, Oliver Smithies, Howard A Rockman.   

Abstract

For over a century, there has been intense debate as to the reason why some cardiac stresses are pathological and others are physiological. One long-standing theory is that physiological overloads such as exercise are intermittent, while pathological overloads such as hypertension are chronic. In this study, we hypothesized that the nature of the stress on the heart, rather than its duration, is the key determinant of the maladaptive phenotype. To test this, we applied intermittent pressure overload on the hearts of mice and tested the roles of duration and nature of the stress on the development of cardiac failure. Despite a mild hypertrophic response, preserved systolic function, and a favorable fetal gene expression profile, hearts exposed to intermittent pressure overload displayed pathological features. Importantly, intermittent pressure overload caused diastolic dysfunction, altered beta-adrenergic receptor (betaAR) function, and vascular rarefaction before the development of cardiac hypertrophy, which were largely normalized by preventing the recruitment of PI3K by betaAR kinase 1 to ligand-activated receptors. Thus stress-induced activation of pathogenic signaling pathways, not the duration of stress or the hypertrophic growth per se, is the molecular trigger of cardiac dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741575      PMCID: PMC1464895          DOI: 10.1172/JCI25397

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress.

Authors:  H Hirota; J Chen; U A Betz; K Rajewsky; Y Gu; J Ross; W Müller; K R Chien
Journal:  Cell       Date:  1999-04-16       Impact factor: 41.582

2.  Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase.

Authors:  D J Choi; W J Koch; J J Hunter; H A Rockman
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

3.  Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure.

Authors:  T Meguro; C Hong; K Asai; G Takagi; T A McKinsey; E N Olson; S F Vatner
Journal:  Circ Res       Date:  1999-04-02       Impact factor: 17.367

4.  Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression.

Authors:  M C Cho; A Rapacciuolo; W J Koch; Y Kobayashi; L R Jones; H A Rockman
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

5.  Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

Authors:  B D Lowes; W Minobe; W T Abraham; M N Rizeq; T J Bohlmeyer; R A Quaife; R L Roden; D L Dutcher; A D Robertson; N F Voelkel; D B Badesch; B M Groves; E M Gilbert; M R Bristow
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  Myosin heavy chain gene expression in human heart failure.

Authors:  K Nakao; W Minobe; R Roden; M R Bristow; L A Leinwand
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

7.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

8.  Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure.

Authors:  K Dipla; J A Mattiello; V Jeevanandam; S R Houser; K B Margulies
Journal:  Circulation       Date:  1998-06-16       Impact factor: 29.690

9.  Sympathetic neural mechanisms in obstructive sleep apnea.

Authors:  V K Somers; M E Dyken; M P Clary; F M Abboud
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

10.  Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy.

Authors:  H A Rockman; R S Ross; A N Harris; K U Knowlton; M E Steinhelper; L J Field; J Ross; K R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

View more
  97 in total

Review 1.  Reverse remodeling in heart failure--mechanisms and therapeutic opportunities.

Authors:  Norimichi Koitabashi; David A Kass
Journal:  Nat Rev Cardiol       Date:  2011-12-06       Impact factor: 32.419

Review 2.  Specific PI3K isoform modulation in heart failure: lessons from transgenic mice.

Authors:  Alessandra Ghigo; Fulvio Morello; Alessia Perino; Federico Damilano; Emilio Hirsch
Journal:  Curr Heart Fail Rep       Date:  2011-09

3.  Nature versus exposure: matched exposure to circulatory stressors of different natures elicits adaptive remodelling.

Authors:  S Wright; R Lakin
Journal:  J Physiol       Date:  2015-11-01       Impact factor: 5.182

Review 4.  The use of human cardiac tissue in biophysical research: the risks of translation.

Authors:  Eias Jweied; Pieter deTombe; Peter M Buttrick
Journal:  J Mol Cell Cardiol       Date:  2007-02-09       Impact factor: 5.000

Review 5.  What do we know about the cardiac benefits of exercise?

Authors:  Xin Wei; Xiaojun Liu; Anthony Rosenzweig
Journal:  Trends Cardiovasc Med       Date:  2014-12-31       Impact factor: 6.677

6.  Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy.

Authors:  Julie R McMullen; Fatemeh Amirahmadi; Elizabeth A Woodcock; Martina Schinke-Braun; Russell D Bouwman; Kimberly A Hewitt; Janelle P Mollica; Li Zhang; Yunyu Zhang; Tetsuo Shioi; Antje Buerger; Seigo Izumo; Patrick Y Jay; Garry L Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

Review 7.  [Pathophysiology of heart failure].

Authors:  T Kempf; H Drexler; K C Wollert
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.743

8.  A proliferative burst during preadolescence establishes the final cardiomyocyte number.

Authors:  Nawazish Naqvi; Ming Li; John W Calvert; Thor Tejada; Jonathan P Lambert; Jianxin Wu; Scott H Kesteven; Sara R Holman; Torahiro Matsuda; Joshua D Lovelock; Wesley W Howard; Siiri E Iismaa; Andrea Y Chan; Brian H Crawford; Mary B Wagner; David I K Martin; David J Lefer; Robert M Graham; Ahsan Husain
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

9.  Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.

Authors:  Camille L Birch; Samantha M Behunin; Marissa A Lopez-Pier; Christiane Danilo; Yulia Lipovka; Chandra Saripalli; Henk Granzier; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

10.  Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury.

Authors:  Dan Frenkel; Alok S Pachori; Lunan Zhang; Adi Dembinsky-Vaknin; Dorit Farfara; Sanja Petrovic-Stojkovic; Victor J Dzau; Howard L Weiner
Journal:  Int Immunol       Date:  2009-06-10       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.